BLFS vs TDOC: Which Stock Is the Better Buy?
BioLife Solutions, Inc. and Teladoc Health, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — BLFS vs TDOC, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| BioLife Solutions, Inc. (BLFS) | Teladoc Health, Inc. (TDOC) | |
|---|---|---|
| Market cap | $1.3B | $1.3B |
| Revenue (latest FY) | $96.21M | $2.53B |
| Net income (latest FY) | $-4.59M | $-200.32M |
| Revenue growth (5y CAGR) | 14.9% | 18.3% |
| Net margin | -4.8% | -7.9% |
| Return on equity | -1.2% | -14.5% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 1 | 0 |
| Positive free cash flow | Yes | Yes |
Verify the comparison
Use the filing period and source shown by each tool before treating two figures as comparable.
See the full BLFS vs TDOC breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open BLFS's full financials → Open TDOC's full financials →More comparisons
Frequently asked questions
Which is bigger, BLFS or TDOC?
BioLife Solutions, Inc. is larger by market capitalization — $1.3B versus $1.3B.
Which grows faster, BLFS or TDOC?
Over the last five fiscal years, Teladoc Health, Inc. grew revenue faster — 18.3%/yr versus 14.9%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
BLFS fundamentals → · TDOC fundamentals → · All 1,500+ companies → · Free screener →